PT2114367E - Formulações de olopatadina para administração nasal tópica - Google Patents
Formulações de olopatadina para administração nasal tópica Download PDFInfo
- Publication number
- PT2114367E PT2114367E PT77501534T PT07750153T PT2114367E PT 2114367 E PT2114367 E PT 2114367E PT 77501534 T PT77501534 T PT 77501534T PT 07750153 T PT07750153 T PT 07750153T PT 2114367 E PT2114367 E PT 2114367E
- Authority
- PT
- Portugal
- Prior art keywords
- nasal administration
- topical nasal
- olopatadine formulations
- olopatadine
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2007/003285 WO2008097220A1 (en) | 2007-02-07 | 2007-02-07 | Olopatadine formulations for topical nasal administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2114367E true PT2114367E (pt) | 2016-02-01 |
Family
ID=38542957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT77501534T PT2114367E (pt) | 2007-02-07 | 2007-02-07 | Formulações de olopatadina para administração nasal tópica |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP2977042B1 (pt) |
| JP (1) | JP5149308B2 (pt) |
| KR (1) | KR20100014858A (pt) |
| CN (1) | CN101621989A (pt) |
| AU (1) | AU2007346121B2 (pt) |
| BR (1) | BRPI0721255B8 (pt) |
| CA (1) | CA2677631C (pt) |
| DK (1) | DK2114367T3 (pt) |
| ES (2) | ES2557939T3 (pt) |
| HK (1) | HK1217090A1 (pt) |
| HU (1) | HUE026162T2 (pt) |
| MX (1) | MX2009008548A (pt) |
| PL (1) | PL2114367T3 (pt) |
| PT (1) | PT2114367E (pt) |
| SI (1) | SI2114367T1 (pt) |
| WO (1) | WO2008097220A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011001317A (ja) * | 2009-06-19 | 2011-01-06 | Fumakilla Ltd | 鼻用洗浄剤 |
| MX2012000539A (es) * | 2009-07-17 | 2012-02-28 | Alcon Res Ltd | Regimen de rocio nasal de olopatadina para niños. |
| KR101271925B1 (ko) * | 2011-02-10 | 2013-06-05 | 비. 김 로버트 | 미네랄 알칼리수 |
| TW201336527A (zh) * | 2012-02-10 | 2013-09-16 | Alcon Res Ltd | 具增強的穩定性之水性藥學組成物 |
| CN103830219A (zh) * | 2012-11-20 | 2014-06-04 | 深圳大佛药业有限公司 | 一种稳定的奥洛他定组合物 |
| CN114980881A (zh) * | 2019-12-06 | 2022-08-30 | 东兴药品工业株式会社 | 包含奥洛他定的鼻用组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| JP3662944B2 (ja) * | 1993-08-24 | 2005-06-22 | 協和醗酵工業株式会社 | 点鼻剤 |
| US5641805A (en) | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| AU776789B2 (en) * | 2000-01-25 | 2004-09-23 | Alcon Inc. | Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| CA2504200A1 (en) * | 2002-11-12 | 2004-05-27 | Alcon, Inc. | The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| DK1814538T3 (da) | 2004-11-24 | 2009-11-02 | Alcon Inc | Fremgangsmåde til administration af næsespray |
-
2007
- 2007-02-07 JP JP2009549052A patent/JP5149308B2/ja active Active
- 2007-02-07 ES ES07750153.4T patent/ES2557939T3/es active Active
- 2007-02-07 EP EP15185071.6A patent/EP2977042B1/en active Active
- 2007-02-07 ES ES15185071T patent/ES2781090T3/es active Active
- 2007-02-07 BR BRPI0721255A patent/BRPI0721255B8/pt active IP Right Grant
- 2007-02-07 PT PT77501534T patent/PT2114367E/pt unknown
- 2007-02-07 CN CN200780051017A patent/CN101621989A/zh active Pending
- 2007-02-07 EP EP07750153.4A patent/EP2114367B1/en active Active
- 2007-02-07 AU AU2007346121A patent/AU2007346121B2/en active Active
- 2007-02-07 HU HUE07750153A patent/HUE026162T2/en unknown
- 2007-02-07 KR KR1020097017832A patent/KR20100014858A/ko not_active Application Discontinuation
- 2007-02-07 DK DK07750153.4T patent/DK2114367T3/en active
- 2007-02-07 PL PL07750153T patent/PL2114367T3/pl unknown
- 2007-02-07 MX MX2009008548A patent/MX2009008548A/es active IP Right Grant
- 2007-02-07 WO PCT/US2007/003285 patent/WO2008097220A1/en active Application Filing
- 2007-02-07 SI SI200731711T patent/SI2114367T1/sl unknown
- 2007-02-07 CA CA2677631A patent/CA2677631C/en active Active
-
2016
- 2016-05-04 HK HK16105086.6A patent/HK1217090A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL2114367T3 (pl) | 2016-03-31 |
| SI2114367T1 (sl) | 2016-01-29 |
| EP2114367B1 (en) | 2015-11-04 |
| KR20100014858A (ko) | 2010-02-11 |
| JP2010518075A (ja) | 2010-05-27 |
| ES2781090T3 (es) | 2020-08-28 |
| ES2557939T3 (es) | 2016-01-29 |
| HK1217090A1 (zh) | 2016-12-23 |
| AU2007346121B2 (en) | 2012-08-23 |
| HUE026162T2 (en) | 2016-05-30 |
| BRPI0721255B1 (pt) | 2019-08-27 |
| CA2677631C (en) | 2014-05-13 |
| DK2114367T3 (en) | 2015-12-07 |
| CN101621989A (zh) | 2010-01-06 |
| MX2009008548A (es) | 2009-08-18 |
| EP2114367A1 (en) | 2009-11-11 |
| WO2008097220A1 (en) | 2008-08-14 |
| BRPI0721255A2 (pt) | 2013-01-01 |
| EP2977042A1 (en) | 2016-01-27 |
| BRPI0721255B8 (pt) | 2021-05-25 |
| EP2977042B1 (en) | 2020-01-01 |
| JP5149308B2 (ja) | 2013-02-20 |
| AU2007346121A1 (en) | 2008-08-14 |
| CA2677631A1 (en) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0706744D0 (en) | Nasal administration | |
| ZA201400071B (en) | Topical formulations having enhanced bioavailability | |
| TWI367110B (en) | Topical pharmaceutical formulation | |
| IL192565A0 (en) | Medicament for topical use | |
| HK1217090A1 (zh) | 用於局部鼻施用的奧洛他定製劑 | |
| ZA201101523B (en) | Linaclotide-containing formulations for oral administration | |
| GB0709513D0 (en) | Topical formulations | |
| BRPI0808293A2 (pt) | "composições para administração nasal" | |
| PT2066179T (pt) | Formulações para administração tópica local contendo indoxacarb | |
| HK1145467A1 (en) | Nasal delivery devices | |
| PL2120822T3 (pl) | System irygacji nosa | |
| EP2152274A4 (en) | NASAL ADMINISTRATION OF BENZODIAZEPINES | |
| EP2226071A4 (en) | COMPOSITIONS FOR ORAL ADMINISTRATION | |
| ZA201003227B (en) | Novel neurturin conjugates for pharmaceutical use | |
| EP2206519A4 (en) | MEDICINAL PREPARATION FOR ORAL ADMINISTRATION | |
| GB0606415D0 (en) | Topical drug delivery | |
| EP2310022A4 (en) | TOPIC MEDICINE | |
| IL198160A0 (en) | Pharmaceutical formulations | |
| BRPI0906045A2 (pt) | "composição farmacêutica para administração nasal" | |
| GB2471973B (en) | Nasal delivery devices | |
| GB0612556D0 (en) | Topical pharmaceutical formulations | |
| ZA200905168B (en) | Olopatadine formulations for topical nasal administration | |
| EP2175918A4 (en) | MANUFACTURE OF COMPONENTS OF MEDICAL DISTRIBUTORS | |
| AU2007905789A0 (en) | Nasal vaporiser device | |
| GB0713093D0 (en) | Pharmaceutical formulations |